Track BB Biotech AG — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BB Biotech AG BION.SW · Stock Open BB Biotech AG in new tab

53.20 CHF
P/E
2.76
EPS
19.57
Yield
4.17%
Safety Score
76
P/B
0.91
ROE
38.68
Beta
0.68
Loading chart...
Key Metrics
Earnings dateFeb. 12, 2027
P/E2.76
EPS19.57
Book Value59.10
Price to Book0.91
% Insiders0.078%
Growth
Revenue Growth-0.61%
Earnings Growth-0.61%
Estimates
Forward P/E-82.10
Forward EPS-0.66
Dividend
Dividend Yield4.17%
Annual dividends2.25 CHF
Ex-Div. DateMarch 23, 2026
Payout11.53%
5y avg Yield5.67%

DCF valuation

Model fair value for BB Biotech AG (BION.SW)
Result
Sign in to run the valuation for BION.SW.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

BB Biotech AG Logo BB Biotech AG Analysis (BION.SW)

Switzerland Healthcare Official Website Stock

Is BB Biotech AG a good investment? BB Biotech AG (BION.SW) is currently trading at 53.20 CHF.

In terms of valuation, the stock trades at a P/E ratio of 2.76. This relatively low multiple may signal that BB Biotech AG is undervalued compared to historical market norms.

Earnings Schedule: BB Biotech AG is expected to release its next earnings report on Feb. 12, 2027. The market consensus estimate for Forward EPS is -0.66.

For income investors, BB Biotech AG pays a dividend yield of 4.17%. With a payout ratio of 12%, the dividend appears sustainable.

Investor FAQ

Does BB Biotech AG pay a dividend?

Yes, it pays an annual dividend of 2.25 CHF (4.17% yield).

What asset class is BB Biotech AG?

BB Biotech AG is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 12, 2027. The company currently has a trailing EPS of 19.57.

Company Profile

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Exchange Ticker
BBZA.DE
SIX BION.SW
Trades
Dividend Yield
4.17%
5y avg 5.67%
Annual Dividends
2.25CHF
Next Ex. Div Date
March 23, 2026
Payout Ratio
11.53%
Dividend History paid per year (CHF)
Historical Dividends
Year Total Dividends
▸2027
2.01 CHF
March 25, 2027 (estimated) 2.0083
▸2026
2.25 CHF
March 25, 2026 2.2500
▸2025
1.80 CHF
March 25, 2025 1.8000
▸2024
2.00 CHF
March 27, 2024 2.0000
▸2023
2.85 CHF
March 29, 2023 2.8500
▸2022
3.85 CHF
March 23, 2022 3.8500
▸2021
3.60 CHF
March 24, 2021 3.6000
▸2020
3.40 CHF
March 25, 2020 3.4000
▸2019
6.10 CHF
May 17, 2019 3.0500
March 27, 2019 3.0500
▸2018
3.30 CHF
March 19, 2018 3.3000
▸2017
2.75 CHF
March 22, 2017 2.7500
▸2016
14.50 CHF
March 23, 2016 14.5000
▸2015
11.60 CHF
March 24, 2015 11.6000
▸2014
7.00 CHF
March 26, 2014 7.0000
▸2013
4.50 CHF
March 25, 2013 4.5000
▸2011
3.20 CHF
March 28, 2011 3.2000
▸2010
3.70 CHF
April 7, 2010 3.7000
▸2009
1.80 CHF
March 31, 2009 1.8000
▸2008
0.90 CHF
April 7, 2008 0.9000
▸2007
2.00 CHF
March 30, 2007 2.0000
▸2006
1.80 CHF
April 26, 2006 1.8000
▸2005
2.40 CHF
April 29, 2005 2.4000
▸2004
2.50 CHF
April 21, 2004 2.5000
Upcoming Dividends
Name Payment Date Status Amount
BB Biotech AG Mar 25, 2026 2.25 CHF
Stock Splits
Split Date Split Ratio to 1
May 18, 2001 10:1
March 29, 2016 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion